MTHFR and Miyoshi myopathy: Until now, the cumulative Z-curve crossed the trial sequential monitoring boundary and the required information size has been reached, confirming that MTHFR C677T polymorphism is associated with increased risk of MM and further relevant trials are unnecessary (Fig. 3).